Member Info for Storey89

You’re right there. It appears easy to trade on the face of it but a mid day RNS and you would be sick as a chip for the sake of a couple of %

I’m surprised Roche are getting as much coverage as they are.

BBI openly states they think the RTC test will be ready for production in June. To put a timescale on it they must be almost there and ready to submit it for validation.

Surely that’s the bigger picture?

Correct me if I’m wrong but Roche have just announced how effective their test is. If they submit it to PHE for validation they’re at least 2 weeks behind Mologic.

They may well join us but I don’t see how they could ‘pip us to the post’

Appreciate what you said is from an article but I don’t understand how.

I think, for your own sake to save face, you may want to comment saying... oops I’m on the wrong board.

I’ve commented on his tweet saying to screenshot the email. Not replying to anybody though which doesn’t back up his claim too well.

Newton seemed a lot more confident than the other two. He would be the one in the know.

There are at least 2 lab based tests being evaluated and looking promising. We know we’re one of them.

Liked the Evening standard, here we go

It’s certainly not for me, been spiked more than enough to be playing that game.

Just one heck of a rise, thought LSE must have been wrong until I checked google.

As this is way off topic but as we’re nearly at the end of the day...

Has anyone seen a bigger rise that Motif Bio in one day?? It’s over 800% on google! What the fudge

You can tell there’s interest here. Normally shares go down at the end of the day as the traders leave.

This goes up as people come back in because they’re terrified of missing a 7am RNS.

Don’t have talk sh*t at times. Read a few articles today saying the Roche test will be rolled out potentially by the end of the week.

Our test has been with PHE for 2 weeks for validation. Roche are ‘at least’ 2 weeks behind us.

The number is far too small to effect the share price.

Selling and then seeing that number of the RNS change to 2... I think I would be physically sick.

selling now. Once the NHS validation lands people will be kicking themselves. Hard.

Not trying to be patronising here at all, not sure what your knowledge of investing is but be careful asking that question on other boards.

Thankfully it’s not the case here but you’ll get a lot of people telling you instantly to invest for their own interests.

With doubts about where this is going listen to the interview on BBI solutions twitter, last tweet, not the pinned one.

RTC potentially ready for mass production by June. To allow for the required sign offs they must have something very advanced for a CEO of a company that big to speak with such confidence.

Was thinking of buying in here this morning but the spread is ridiculous.

I know what you guys will say, just buy in, in won’t matter in the end... but it’s very off putting.

Is it normally this big?

What does it matter what Roche are doing, I don’t know if people have noticed but NCYT aren’t the only Antigen around.

How are people genuinely surprised other companies are coming up with tests as well.

Did they expect us to be the only one in the world?

We’ve got the CE mark, are in production, backed by the Government and just awaiting NHS validation.

Chill the f*** out.